Expression of PYCARD gene transcript variant mRNA in peripheral blood mononuclear cells of primary gout patients with different Chinese medicine syndromes

Wan-tai Dang; Wen-guang Xie; Jing-guo Zhou

doi:10.1007/s11655-017-2826-9

Your Location：

Home >

Browse articles >

Expression of PYCARD gene transcript variant mRNA in peripheral blood mononuclear cells of primary gout patients with different Chinese medicine syndromes

OriginalPaper | Updated：2021-08-27

- Expression of PYCARD gene transcript variant mRNA in peripheral blood mononuclear cells of primary gout patients with different Chinese medicine syndromes
- Expression of PYCARD gene transcript variant mRNA in peripheral blood mononuclear cells of primary gout patients with different Chinese medicine syndromes
- 中国结合医学杂志（英文版） 2018年24卷第1期页码：24-31
- Affiliations：
  
  1. School of Clinical Medicine, Chengdu University of Traditional Chinese Medicine,Chengdu,China
  2. Institute of Rheumatology and Immunology, Affiliated Hospital of North Sichuan Medical College, Nanchong,Sichuan Province,China
- Author bio：
- Funds：
  
  Supported by the National Natural Science Foundation of China (No. 81603441), Educational Commission of Sichuan Province (No. 16ZA0282), and the China Postdoctoral Science Foundation (No. 2016M590872), China
- DOI：10.1007/s11655-017-2826-9
  中图分类号：
- 纸质出版日期：2018，
  
  网络出版日期：2017-10-30，
Scan for full text
Dang, Wt., Xie, Wg. & Zhou, Jg. Expression of PYCARD gene transcript variant mRNA in peripheral blood mononuclear cells of primary gout patients with different Chinese medicine syndromes., Chin. J. Integr. Med. 24, 24–31 (2018). https://doi.org/10.1007/s11655-017-2826-9

Wan-tai Dang, Wen-guang Xie, Jing-guo Zhou. Expression of PYCARD gene transcript variant mRNA in peripheral blood mononuclear cells of primary gout patients with different Chinese medicine syndromes[J]. Chinese Journal of Integrative Medicine, 2018,24(1):24-31.
Dang, Wt., Xie, Wg. & Zhou, Jg. Expression of PYCARD gene transcript variant mRNA in peripheral blood mononuclear cells of primary gout patients with different Chinese medicine syndromes., Chin. J. Integr. Med. 24, 24–31 (2018). https://doi.org/10.1007/s11655-017-2826-9 DOI：

Wan-tai Dang, Wen-guang Xie, Jing-guo Zhou. Expression of PYCARD gene transcript variant mRNA in peripheral blood mononuclear cells of primary gout patients with different Chinese medicine syndromes[J]. Chinese Journal of Integrative Medicine, 2018,24(1):24-31. DOI： 10.1007/s11655-017-2826-9.

摘要

To study the expression level and role of apoptosis-associated speck-like protein containing a caspase recruitment domain (PYCARD) gene transcript variant mRNA in peripheral blood mononuclear cells (PBMCs) of primary gout (PG) patients with different Chinese medicine (CM) syndromes. The expressions of PYCARD gene transcript variant mRNA and interleukin-1β (IL-1β) mRNA in PBMCs were investigated in 96 PG patients with acute phase (APPG

44 cases) and non-acute phase (NAPPG

52 cases) and 30 healthy controls (HCs) by reverse transcription-polymerase chain reaction (PCR) and/or realtime quantitative PCR. PYCARD and nuclear factor-κB (p50) [NF-κB (p50)] protein was detected by Western blot in PBMCs respectively. IL-1β

IL-4 and IL-10 protein levels in plasma of HCs and PG patients were measured by enzyme-linked immuno sorbent assay. The main CM syndromes in APPG patients were obstruction of dampness and heat syndrome (ODHS

36.36%) and intermingled phlegm-blood stasis syndrome (IPBSS

27.27%)

while in NAPPG patients were Pi (Spleen)-deficiency induced dampness syndrome (PDIDS

40.38%) and qi-blood deficiency syndrome (QBDS

26.92%). It showed statistical significances of the expressions of PYCARD gene and its transcript variant mRNA

the protein of PYCARD and NF-κB (p50) and the plasma IL-1β

IL-4 and IL-10 in APPG

NAPPG

ODHS

IPBSS

PDIDS and QBDS groups

compared with the HC group respectively (P<0.05 or P<0.01). There were also significant differences of mRNA expressions of PYCARD-1 and PYCARD-2 as well as protein expressions of IL-1β

IL-4 and IL-10 among the 4 CM syndromes groups (P<0.05 or P<0.01). Correlation analysis showed positive correlation between the mRNA expressions of PYCARD-1 gene transcript variant and IL-1β in APPG patients (r=0.3088

P=0.0183). PYCARD gene and its transcript variant may play a critical and regulative role in the inflflammatory response of PG patients with different phases and CM syndromes.

Abstract

44 cases) and non-acute phase (NAPPG

36.36%) and intermingled phlegm-blood stasis syndrome (IPBSS

27.27%)

while in NAPPG patients were Pi (Spleen)-deficiency induced dampness syndrome (PDIDS

40.38%) and qi-blood deficiency syndrome (QBDS

26.92%). It showed statistical significances of the expressions of PYCARD gene and its transcript variant mRNA

the protein of PYCARD and NF-κB (p50) and the plasma IL-1β

IL-4 and IL-10 in APPG

NAPPG

ODHS

IPBSS

PDIDS and QBDS groups

compared with the HC group respectively (P<0.05 or P<0.01). There were also significant differences of mRNA expressions of PYCARD-1 and PYCARD-2 as well as protein expressions of IL-1β

P=0.0183). PYCARD gene and its transcript variant may play a critical and regulative role in the inflflammatory response of PG patients with different phases and CM syndromes.

关键词

Chinese medicine syndromeprimary goutPYCARDgenetranscript variant

Keywords

Chinese medicine syndromeprimary goutPYCARDgenetranscript variant

references

Richette P, Bardin T. Gout. Lancet 2010;375:318–328.

Chang HY, Pan WH, Yeh WT, Tsai KS. Hyperuricemia and gout in Taiwan: results from the nutritional and health survey in Taiwan (1993–96). J Rheumatol 2001;28:1640–1646.

Miao Z, Li C, Chen Y, Zhao S, Wang Y, Wang Z, et al. Dietary and lifestyle changes associated with high prevalence of hyperuricemia and gout in the Shandong coastal cities of Eastern China. J Rheumatol 2008;35:1859–1864.

Rock KL, Kataoka H, Lai JJ. Uric acid as a danger signal in gout and its comorbidities. Nat Rev Rheumatol 2013;9:13–23.

Pope RM, Tschopp J. The role of interleukin-1 and the inflammasome in gout: implications for therapy. Arthrit Rheum 2007;56:3183–3188.

Sidiropoulos PI, Goulielmos G, Voloudakis GK, Petraki E, Boumpas DT. Inflammasomes and rheumatic diseases: evolving concepts. Ann Rheum Dis 2008;67:1382–1389.

Shi Y, Evans JE, Rock KL. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 2003;425:516–521.

Srinivasula SM, Poyet JL, Razmara M, Datta P, Zhang Z, Alnemri ES. The PYRIN-CARD protein ASC is an activating adaptor for caspase-1. J Biol Chem 2002;277:21119–21122.

Stehlik C, Lee SH, Dorfleutner A, Stassinopoulos A, Sagara J, Reed JC. Apoptosis-associated speck-like protein containing a caspase recruitment domain is a regulator of procaspase-1 activation. J Immunol 2003;171:6154–6163.

Cai X, Chen J, Xu H, Liu S, Jiang QX, Halfmann R, et al. Prion-like polymerization underlies signal transduction in antiviral immune defense and inflammasome activation. Cell 2014;156:1207–1222.

Masumoto J, Taniguchi S, Nakayama J, Shiohara M, Hidaka E, Katsuyama T, et al. Expression of apoptosisassociated speck-like protein containing a caspase recruitment domain, a pyrin N-terminal homology domaincontaining protein, in normal human tissues. J Histochem Cytochem 2001;49:1269–1275.

Fernandes-Alnemri T, Wu J, Yu JW, Datta P, Miller B, Jankowski W, et al. The pyroptosome: a supramolecular assembly of ASC dimmers mediating inflammatory cell death via caspase-1 activation. Cell Death Differ 2007;14:1590–1604.

Broz P, Newton K, Lamkanfi M, Mariathasan S, Dixit VM, Monack DM. Redundant roles for inflammasome receptors NLRP3 and NLRC4 in host defense against Salmonella. J Exp Med 2010;207:1745–1755.

Martinon F, Pétrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006;440:237–241.

Modrek B, Resch A, Grasso C, Lee C. Genome-wide detection of alternative splicing in expressed sequences of human genes. Nucleic Acids Res 2001;29:2850–2859.

Gueroussov S, Weatheritt RJ, O'Hanlon D, Lin ZY, Narula A, Gingras AC, et al. Regulatory expansion in mammals of multivalent hnRNP assemblies that globally control alternative splicing. Cell 2017;170:324–339.

Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yü TF. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthrit Rheum 1977;20:895–900.

Dang WT, Zhou JG, Xie WG, Cai Y, Qing YF, Qiu Y, et al. Expression of NLRP3 gene transcript variant mRNA in the peripheral blood mononuclear cells of patients with primary gout. Chin J Rheumatol (Chin) 2014;18:76–81.

Dang WT, Zhou JG, Xie WG, Cai Y, Guo XL, Zhao MC, et al. Mechanism of NLRP3 inflammasome in inflammatory response with gouty arthritis. Chin J Immunol (Chin) 2014;30:373–377.

State Bureau of Technical Supervision. The type of part, clinical diagnosis and treatment of traditional Chinese medicine terminology. Beijing: Standards Press of China;1997:223–225.

Zheng XY, ed. Guiding principle of clinical research on new drugs of traditional Chinese medicine. Beiing: Chinese Medicine Science and Technology Press; 1995:179–183.

Dang WT, Zhou JG, Xie WG, Qing YF, Pan SY, Zhang MY, et al. Comparative analysis of clinical indicators of gout patients of different syndrome types and its significance. Chin J Integr Tradit West Med (Chin) 2013;33:1323–1327.

Dang WT, Zhou JG, Xie WG, Cai Y, Qing YF, Qiu Y, et al. Expression of caspase-1 gene transcript variant mRNA in peripheral blood monocytes of patients with primary gout. Chin J Rheumatol (Chin) 2014;18:400–404.

Tanner C, Boocock J, Stahl EA, Dobbyn A, Mandal AK, Cadzow M, et al. Population-specific resequencing associates the ATP-binding cassette subfamily C member 4 gene with gout in New Zealand M ori and Pacific men. Arthrit Rheumatol 2017;69:1461–1469.

Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, et al. Alternative isoform regulation in human tissue transcriptomes. Nature 2008;456:470–476.

Moore MJ, Wang Q, Kennedy CJ, Silver PA. An alternative splicing network links cell-cycle control to apoptosis. Cell 2010;142:625–636.

Barash Y, Calarco JA, Gao W, Pan Q, Wang X, Shai O, et al. Deciphering the splicing code. Nature 2010;465:53–59.

Liu XD, Wang YQ, Cai L, Ye LH, Wang F, Feng YY. Effect of Wenhua Juanbi Recipe on expression of receptor activator of nuclear factor kappa B ligand, osteoprotegerin, and tumor necrosis factor receptor superfamily member 14 in rats with collagen-induced arthritis. Chin J Integr Med 2017;23:208–214.

Kong YJ, Zhang QD, Wei MX. Can new diagnostic criteria of rheumatoid arthritis really make an early diagnosis? A case report of early diagnosis and treatment of early rheumatoid arthritis with Chinese medicine. Chin J Integr Med 2016;22:237–240.

FULL TEXT LINK

More>

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Yin-yang and Zheng: Exported from Chinese medicine

Application of metabolomics technology in the research of Chinese medicine

Analysis on the Chinese medicine syndromes and demographic characteristics of patients with influenza-like illness in clinics of China

Exploring molecular mechanism underlying Chinese medicine syndrome: A study on correlation between Chinese medicine syndrome and biomarkers for ischemic stroke

Bone marrow angiogenesis in patients presenting with differential Chinese medicine syndrome: Correlation with the clinico-pathological features of aplastic anemia